MD/PhD | Geneoscopy CMO/CSO | Forbes 30 Under 30
St Louis, MO
Joined February 2018
- Tweets248
- Following161
- Followers312
- Likes1.1K
Erica Barnell retweeted
FOR IMMEDIATE RELEASE:
Geneoscopy Sibling Co-founders Named Finalists for EY Entrepreneur Of The Year 2025 Heartland Award
"@EricaBarnell and I have always focused on building a strong business foundation—scaling our operations, hiring the right people to advance our mission and technology, establishing key partnerships, and setting the stage for long-term growth. We're honored to be recognized by EY among such an inspiring group of entrepreneurs." — @AndrewBarnell, MBA, CEO and co-founder of Geneoscopy.
Read the full release here: bit.ly/4jslhyN
#EOYUS #EOYHL @EY_US
Erica Barnell retweeted
FOR IMMEDIATE RELEASE: Geneoscopy secures $105M Series C funding led by @BioRad to launch ColoSense®, a non-invasive colorectal cancer screening test, and drive IBD diagnostic innovation.
Read more: bit.ly/GeneoscopySeriesC
#InnovativeDiagnostics #ColorectalCancer #IBD #GITwitter
Erica Barnell retweeted
Digestive Disease Week 2024 provided an excellent opportunity to showcase Geneoscopy's RNA technology and connect with others dedicated to transforming gastrointestinal health.
Read more: bit.ly/3yFlcVU
#DDW2024 #GIHealth #RNAbiomarkers #IBD #CRC #PrecisionMedicine
ALT Geneoscopy advances mission to transform gastrointestinal health
Erica Barnell retweeted
🤩 Day 1 @DDWMeeting for our team across topics:
- Single cell analyses/spatial transcriptomics in perianal Crohn’s & Crohn’s IPAA
- Eukaryotic stool RNA in predicting disease activity/response
- PET CT serial data in perianal fistulas
- Clin predictors urgency in UC @SPARCIBD – at Washington, DC
Erica Barnell retweeted
Incredible work by @EricaBarnell, Andrew Barnell, and the whole @GeneoscopyCo team.
I've had the opportunity to watch their journey since nearly the start. They are truly outstanding founders who have built an incredible company that will make a huge impact on patients for years to come.
Geneoscopy is thrilled to announce the FDA approval of #ColoSense, our noninvasive multi-target stool RNA-based #ColorectalCancer screening test--the first to use patented #RNA technology to provide a dynamic view of disease activity. bit.ly/ColoSenseFDAApproval #EarlyDetection
ALT ColoSense Now FDA-Approved
Erica Barnell retweeted
Geneoscopy is thrilled to announce the FDA approval of #ColoSense, our noninvasive multi-target stool RNA-based #ColorectalCancer screening test--the first to use patented #RNA technology to provide a dynamic view of disease activity. bit.ly/ColoSenseFDAApproval #EarlyDetection
ALT ColoSense Now FDA-Approved
After being a student at @WUSTLmed for nearly a decade, it is an honor to be highlighted as an alumna by the Washington Magazine
source.wustl.edu/2024/04/nex…
Erica Barnell retweeted
Great session at @AACR on advancement in colorectal cancer screening tests! These experts @drfolamay @IssakaMD & @samirguptaGI are the best of the best! This field has so much potential! #AACR24 #AACRSSP #crcsm #ayacsm
Erica Barnell retweeted
Wonderful to see Dr. Lieberman present the results of the @GeneoscopyCo CRC-PREVENT study. Having options for patients can help more of them receive treatment needed to save lives. Congrats Dr. @EricaBarnell and team!
#CRCscreening
#45isthenew50
#ACG2023
@AmCollegeGastro
Erica Barnell retweeted
As we wrap up our time at #ACG2023 we leave invigorated with new hopeful knowledge learned and relationships strengthened. Vancouver didn’t disappoint! Safe travels to all our colleagues!
@GeneoscopyCo
@EricaBarnell
@AmCollegeGastro
#45isthenew50
#CRCscreening
Erica Barnell retweeted
Gratitude and thanks for everyone who joined us at The B.I.G. Event Vancouver! ✨ It was an evening filled with meaningful connections and networking that warmed our hearts. #thebigEventVancouver #blackingastro #ACG2023
Erica Barnell retweeted
In individuals 45 years and older, a multitarget stool RNA test showed high sensitivity for colorectal neoplasia (colorectal cancer and advanced adenoma) with significant improvement in sensitivity relative to the fecal immunochemical test.
ja.ma/473Ry8H
#ACG2023
Erica Barnell retweeted
In individuals 45 years and older, a multitarget stool RNA test showed high sensitivity for colorectal neoplasia (colorectal cancer and advanced adenoma) with significant improvement in sensitivity relative to the fecal immunochemical test.
ja.ma/471pOBH
#ACG2023
Erica Barnell retweeted
JAMA (@JAMA_current) publishes Geneoscopy’s Pivotal CRC-PREVENT Trial results, reporting highest sensitivity for detecting colorectal cancer and advanced adenomas among available noninvasive screening tests: bit.ly/3FqSOag
#JAMA #GITwitter #Screening #colorectalcancer
ALT Geneoscopy's CRC-PREVENT trial published in JAMA
I am officially published in @JAMA_current See results from @GeneoscopyCo's CRC-PREVENT clinical trial for our lead assay in colorectal cancer screening (pending FDA approval):
jamanetwork.com/journals/jam…
Erica Barnell retweeted
Genoscopy In The News: bit.ly/3Je1lke
#RNABiomarkers #PMA #FDA #ColonCancerScreening #ClosingTheGap #NonInvasive
Erica Barnell retweeted
In a @GoHealio #GI interview, @EricaBarnell announced favorable results from @GeneoscopyCo's #CRC-PREVENT trial, which assessed noninvasive, stool-based, at-home screening for #colorectalcancer and advanced #adenomas. #GITwitter #Oncology bit.ly/3izve3h
@GeneoscopyCo releases top-line data for our CRC-PREVENT clinical trial. Prospective pivotal study with 8,292 patients average-risk for CRC:
94% sensitivity for CRC
45% sensitivity for AA
88% specificity for no findings on colonoscopy
prnewswire.com/news-releases…
Erica Barnell retweeted
I’m really pleased to share this paper from @EricaBarnell et al on Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. 1/n ashpublications.org/bloodadv…